These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9397340)

  • 21. Health economic models: a question of balance--summary of an open discussion on the pharmacoeconomic evaluation of non-steroidal anti-inflammatory drugs.
    Drummond MF
    Rheumatology (Oxford); 2000 Dec; 39 Suppl 2():29-32. PubMed ID: 11276799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applying temporal joins to clinical databases.
    O'Connor MJ; Tu SW; Musen MA
    Proc AMIA Symp; 1999; ():335-9. PubMed ID: 10566376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacoeconomics: state of the art in 1997.
    Schulman KA; Linas BP
    Annu Rev Public Health; 1997; 18():529-48. PubMed ID: 9143730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of the pharmacoeconomics of pharmacogenetics.
    Dervieux T; Bala MV
    Pharmacogenomics; 2006 Dec; 7(8):1175-84. PubMed ID: 17184205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview.
    Dasbach EJ; Elbasha EH
    Pharmacoeconomics; 2017 Jul; 35(7):673-683. PubMed ID: 28456972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacoeconomics--an aid to better decision-making.
    Arenas-Guzman R; Tosti A; Hay R; Haneke E;
    J Eur Acad Dermatol Venereol; 2005 Sep; 19 Suppl 1():34-9. PubMed ID: 16120204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Time-Trend Economic Analysis of Cancer Drug Trials.
    Cressman S; Browman GP; Hoch JS; Kovacic L; Peacock SJ
    Oncologist; 2015 Jul; 20(7):729-36. PubMed ID: 26032135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Principles of pharmacoeconomic analysis of drug therapy.
    Freund DA; Dittus RS
    Pharmacoeconomics; 1992 Jan; 1(1):20-31. PubMed ID: 10147037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmaceutical economics of child psychiatric drug treatment.
    Schlander M
    Curr Pharm Des; 2010; 16(22):2443-61. PubMed ID: 20513230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The future of pharmacoeconomics: a commentary.
    Langley PC
    Clin Ther; 1997; 19(4):762-9; discussion 760-1. PubMed ID: 9377619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacoeconomic concepts in antiplatelet therapy: understanding cost-effectiveness analyses using clopidogrel as an example.
    Weintraub WS
    J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):107-19. PubMed ID: 18495905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacoeconomic issues in the treatment of depression.
    Cohen LJ
    Formulary; 1995 Sep; 30 Suppl 1():S20-5. PubMed ID: 10151739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simulation and matching-based approaches for indirect comparison of treatments.
    Ishak KJ; Proskorovsky I; Benedict A
    Pharmacoeconomics; 2015 Jun; 33(6):537-49. PubMed ID: 25795232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extensions to the time-oriented database model to support temporal reasoning in medical expert systems.
    Kahn MG; Fagan LM; Tu S
    Methods Inf Med; 1991; 30(1):4-14. PubMed ID: 2005832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the pharmacoeconomic literature.
    Milne RJ
    Pharmacoeconomics; 1994 Oct; 6(4):337-45. PubMed ID: 10147470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The analysis of censored treatment cost data in economic evaluation.
    Fenn P; McGuire A; Phillips V; Backhouse M; Jones D
    Med Care; 1995 Aug; 33(8):851-63. PubMed ID: 7637406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A practical object-oriented approach to a development of a next generation hospital information system.
    Sakamoto N
    Stud Health Technol Inform; 1998; 52 Pt 2():957-61. PubMed ID: 10384601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of pharmacoeconomics analyses to health protection].
    Drozd M
    Wiad Lek; 2002; 55 Suppl 1():76-9. PubMed ID: 15002222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace.
    Sollano JA; Kirsch JM; Bala MV; Chambers MG; Harpole LH
    Clin Pharmacol Ther; 2008 Aug; 84(2):263-6. PubMed ID: 18547999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.